Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,646 | 355 | 98.8% |
| Education | $58.69 | 5 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $577.09 | 37 | $0 (2021) |
| Corcept Therapeutics | $466.63 | 46 | $0 (2020) |
| Lilly USA, LLC | $439.09 | 48 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $437.23 | 28 | $0 (2020) |
| PFIZER INC. | $359.42 | 27 | $0 (2020) |
| GlaxoSmithKline, LLC. | $356.43 | 29 | $0 (2020) |
| Novo Nordisk Inc | $322.87 | 25 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $251.88 | 15 | $0 (2020) |
| Insulet Corporation | $211.60 | 14 | $0 (2022) |
| Allergan, Inc. | $209.90 | 19 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $122.13 | 7 | Abbott Laboratories ($53.49) |
| 2021 | $67.63 | 5 | Amgen Inc. ($17.35) |
| 2020 | $508.06 | 32 | Corcept Therapeutics ($86.17) |
| 2019 | $1,056 | 88 | PFIZER INC. ($170.94) |
| 2018 | $1,405 | 107 | AstraZeneca Pharmaceuticals LP ($169.59) |
| 2017 | $1,545 | 121 | AstraZeneca Pharmaceuticals LP ($236.98) |
All Payment Transactions
360 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/28/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: Diabetes Care | ||||||
| 08/18/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.15 | General |
| Category: Cardiovascular | ||||||
| 06/02/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Diabetes Care | ||||||
| 04/05/2022 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $24.14 | General |
| Category: Insulin Pump | ||||||
| 03/31/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.11 | General |
| Category: NEUROSCIENCE | ||||||
| 02/07/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Diabetes Care | ||||||
| 01/27/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: NEUROSCIENCE | ||||||
| 12/20/2021 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $13.27 | General |
| Category: Insulin Pump | ||||||
| 10/18/2021 | Abbott Laboratories | FreeStyle Libre 2 (Device) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Diabetes Care | ||||||
| 06/09/2021 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Bone Health | ||||||
| 03/23/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Education | In-kind items and services | $11.56 | General |
| Category: Respiratory | ||||||
| 02/23/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.12 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2020 | Abbott Laboratories | FreeStyle Libre (Device) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Diabetes Care | ||||||
| 10/10/2020 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Endocrinology | ||||||
| 09/29/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: NEUROSCIENCE | ||||||
| 09/23/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: RESPIRATORY | ||||||
| 09/09/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: RESPIRATORY | ||||||
| 09/02/2020 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Endocrinology | ||||||
| 09/02/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.12 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2020 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: Respiratory | ||||||
| 08/13/2020 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $16.61 | General |
| Category: Insulin Pump | ||||||
| 08/05/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: RESPIRATORY | ||||||
| 08/04/2020 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: Endocrinology | ||||||
| 07/30/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/21/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLATRO, STEGLUJAN | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 845 | 1,187 | $284,903 | $83,254 |
| 2022 | 9 | 980 | 1,413 | $360,585 | $101,588 |
| 2021 | 8 | 983 | 1,421 | $382,079 | $111,881 |
| 2020 | 9 | 925 | 1,170 | $307,094 | $77,613 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 378 | 632 | $152,061 | $45,163 | 29.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 206 | 206 | $90,277 | $25,966 | 28.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 164 | 217 | $35,594 | $10,683 | 30.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 29 | 30 | $2,868 | $806.66 | 28.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 52 | 57 | $1,898 | $352.34 | 18.6% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 16 | 45 | $2,205 | $282.22 | 12.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 397 | 761 | $177,191 | $48,651 | 27.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 222 | 222 | $94,085 | $27,997 | 29.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 193 | 259 | $40,958 | $11,659 | 28.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 47 | 47 | $29,434 | $7,642 | 26.0% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 20 | 20 | $8,180 | $2,250 | 27.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 15 | 15 | $3,562 | $1,968 | 55.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 28 | 30 | $2,781 | $754.41 | 27.1% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 13 | 13 | $2,909 | $413.34 | 14.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2022 | 45 | 46 | $1,485 | $254.25 | 17.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 424 | 814 | $183,743 | $54,104 | 29.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 151 | 151 | $91,449 | $25,131 | 27.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 129 | 129 | $53,352 | $16,914 | 31.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 165 | 208 | $31,841 | $9,601 | 30.2% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 36 | 38 | $15,182 | $4,462 | 29.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 11 | 11 | $3,267 | $898.66 | 27.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 17 | 18 | $1,623 | $435.75 | 26.8% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Office | 2021 | 50 | 52 | $1,622 | $335.50 | 20.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 397 | 609 | $134,028 | $31,000 | 23.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2020 | 122 | 122 | $72,686 | $20,678 | 28.4% |
About Dr. Roberto Pabalate, MD
Dr. Roberto Pabalate, MD is a Family Medicine healthcare provider based in Forsyth, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/09/2008. The National Provider Identifier (NPI) number assigned to this provider is 1528221504.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Roberto Pabalate, MD has received a total of $4,705 in payments from pharmaceutical and medical device companies, with $122.13 received in 2022. These payments were reported across 360 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($4,646).
As a Medicare-enrolled provider, Pabalate has provided services to 3,733 Medicare beneficiaries, totaling 5,191 services with total Medicare billing of $374,336. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Forsyth, IL
- Active Since 07/09/2008
- Last Updated 04/04/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1528221504
Products in Payments
- Korlym (Drug) $466.63
- JARDIANCE (Drug) $388.76
- FARXIGA (Drug) $329.41
- Omnipod (Device) $211.60
- CHANTIX (Drug) $209.85
- TRELEGY ELLIPTA (Drug) $189.62
- TRULICITY (Drug) $172.61
- ELIQUIS (Drug) $169.46
- Victoza (Drug) $157.89
- SYMBICORT (Drug) $142.74
- VRAYLAR (Drug) $130.85
- XARELTO (Drug) $124.22
- JANUVIA (Drug) $119.27
- Prolia (Biological) $118.15
- STIOLTO (Drug) $105.59
- Ozempic (Drug) $93.12
- PRALUENT (Drug) $91.63
- Trintellix (Drug) $86.64
- ANORO (Drug) $70.11
- ENTRESTO (Drug) $68.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Forsyth
Laurie Cochran, M.d, M.D
Family Medicine — Payments: $9,476
William Taunton, Md, MD
Family Medicine — Payments: $7,874
Frdaniel Boyd, M.d, M.D
Family Medicine — Payments: $836.53
Ainny Shamim, Md, MD
Family Medicine — Payments: $178.88
Hannah Prater, Fnp-C, FNP-C
Family Medicine — Payments: $132.41
Dr. Michael Wall, M.d, M.D
Family Medicine — Payments: $102.60